Data have shown that positive expression of the CHD1L protein is significantly associated with the metastasis of ovarian carcinoma; therefore, CHD1L protein expression, as examined by immunohistochemistry, may act as a novel prognostic biomarker for patients with ovarian carcinoma (13). This evidence concerns the gene CHD1L and ovarian carcinoma.